MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
0.811
+0.019 (2.36%)
At close: Feb 27, 2026, 4:00 PM EST
0.827
+0.016 (1.95%)
After-hours: Feb 27, 2026, 7:56 PM EST
MaxCyte Stock Forecast
MXCT's stock price has decreased by -77.08% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for MaxCyte stock have an average target of 7.50, with a low estimate of 6.00 and a high estimate of 9.00. The average target predicts an increase of 824.44% from the current stock price of 0.81.
Analyst Consensus: Buy
* Price targets were last updated on Jul 22, 2025.
Analyst Ratings
The average analyst rating for MaxCyte stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 11, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 7, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $6 | Buy | Initiates | $6 | +639.55% | Jul 22, 2025 |
| Stifel | Stifel | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +1,009.33% | Mar 12, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $11 | Buy | Reiterates | $11 | +1,255.85% | Apr 23, 2024 |
Financial Forecast
Revenue This Year
35.73M
from 38.63M
Decreased by -7.50%
Revenue Next Year
39.17M
from 35.73M
Increased by 9.64%
EPS This Year
-0.41
from -0.39
EPS Next Year
-0.28
from -0.41
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 37.9M | 42.8M | ||||
| Avg | 35.7M | 39.2M | ||||
| Low | 32.5M | 36.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.9% | 19.9% | ||||
| Avg | -7.5% | 9.6% | ||||
| Low | -15.8% | 1.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.41 | -0.21 | |
| Avg | -0.41 | -0.28 | |
| Low | -0.40 | -0.44 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.